Rahkola-Soisalo, Päivi
Savolainen-Peltonen, Hanna
Gissler, Mika
Hoti, Fabian
Vattulainen, Pia
Ylikorkala, Olavi
Mikkola, Tomi S.
Article History
Received: 6 March 2018
Accepted: 28 May 2018
First Online: 26 June 2018
Compliance with ethical standards
:
: PR-S has received funding for congress attendance from Johnson & Johnson and Astellas Pharma. HS-P has been a speaker for Mylan and received funding for congress attendance from Mylan and MSD. TM has been a speaker and/or received consulting fees from Mylan and Astellas Pharma.MG and OY have nothing to disclose. FH and PV work for EPID Research. EPID Research is a company that performs financially supported studies for several pharmaceutical companies.